Allergan, Molecular Partners eye drug meets main goal in two studies

Allergan Plc and Molecular Partners AG said on Thursday their treatment for age-related macular degeneration met the main goal in two late-stage studies.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news